MRNA
📉 Moderna’s stock has fallen 64% in the last 12 months due to declining vaccine sales.
⚠️ Investing in broad ETFs can expose investors to companies with weakening business models.
🚫 Diversification does not always mitigate the risk of holding poorly performing stocks.
@InvertirdesdeCero:
“We find companies like the pharmaceutical company Moderna, which has a 64% drop in the stock market in the last 12 months, since its business was based on selling only vaccines against COVID, something that is obviously a declining business.”
Watch the exact part of the video where Fernando talks about Moderna here:
Watch the video on YouTube.
Read more articles by the world’s top 100 analysts on Moderna (MRNA) at the following link. MRNA stock.
